X-30236701-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_002365.5(MAGEB3):āc.777G>Cā(p.Glu259Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000578 in 1,210,829 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 1 hem., cov: 24)
Exomes š: 0.0000046 ( 0 hom. 2 hem. )
Consequence
MAGEB3
NM_002365.5 missense
NM_002365.5 missense
Scores
1
6
10
Clinical Significance
Conservation
PhyloP100: -0.469
Genes affected
MAGEB3 (HGNC:6810): (MAGE family member B3) This gene is a MAGE-B subfamily member of the MAGE gene family. MAGE family member proteins direct the expression of tumor antigens recognized on a human melanoma by autologous cytolytic T lymphocytes. There are two known clusters of MAGE genes on chromosome X. The members of the MAGE-A subfamily are located in the Xq28 region, while the members of the MAGE-B subfamily are clustered in the Xp21 region. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.40430927).
BS2
High Hemizygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEB3 | NM_002365.5 | c.777G>C | p.Glu259Asp | missense_variant | 5/5 | ENST00000361644.4 | NP_002356.2 | |
MAGEB3 | NM_001386865.1 | c.777G>C | p.Glu259Asp | missense_variant | 3/3 | NP_001373794.1 | ||
MAGEB3 | XM_011545513.3 | c.777G>C | p.Glu259Asp | missense_variant | 4/4 | XP_011543815.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEB3 | ENST00000361644.4 | c.777G>C | p.Glu259Asp | missense_variant | 5/5 | 2 | NM_002365.5 | ENSP00000355198.2 | ||
MAGEB3 | ENST00000620842.1 | c.777G>C | p.Glu259Asp | missense_variant | 1/1 | 6 | ENSP00000478513.1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112626Hom.: 0 Cov.: 24 AF XY: 0.0000288 AC XY: 1AN XY: 34766
GnomAD3 genomes
AF:
AC:
2
AN:
112626
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34766
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183405Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67845
GnomAD3 exomes
AF:
AC:
2
AN:
183405
Hom.:
AF XY:
AC XY:
1
AN XY:
67845
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000455 AC: 5AN: 1098203Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 2AN XY: 363557
GnomAD4 exome
AF:
AC:
5
AN:
1098203
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
363557
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112626Hom.: 0 Cov.: 24 AF XY: 0.0000288 AC XY: 1AN XY: 34766
GnomAD4 genome
AF:
AC:
2
AN:
112626
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34766
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.777G>C (p.E259D) alteration is located in exon 5 (coding exon 1) of the MAGEB3 gene. This alteration results from a G to C substitution at nucleotide position 777, causing the glutamic acid (E) at amino acid position 259 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Loss of ubiquitination at K256 (P = 0.1446);Loss of ubiquitination at K256 (P = 0.1446);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at